13^th World Gastro Summit

Advances in Gastrointestinal Cancer Management

Gastrointestinal (GI) cancers represent a diverse group of malignancies that affect organs within the digestive system, including the esophagus, stomach, liver, pancreas, colon, and rectum. These cancers are a major contributor to global cancer-related morbidity and mortality. Due to their varied etiologies and progression patterns, GI cancers require individualized treatment strategies. Current therapeutic approaches—such as surgical resection, chemotherapy, radiotherapy, immunotherapy, and molecularly targeted agents—are often combined to enhance outcomes. A multidisciplinary framework involving oncologists, gastroenterologists, surgeons, radiologists, and pathologists is essential for personalized treatment planning and improved patient survival.